SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-302150
Filing Date
2023-12-22
Accepted
2023-12-22 16:30:04
Documents
12
Period of Report
2023-12-18
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d668785d8k.htm   iXBRL 8-K 24668
  Complete submission text file 0001193125-23-302150.txt   146330

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA hrtx-20231218.xsd EX-101.SCH 2851
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrtx-20231218_lab.xml EX-101.LAB 17995
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrtx-20231218_pre.xml EX-101.PRE 11262
6 EXTRACTED XBRL INSTANCE DOCUMENT d668785d8k_htm.xml XML 3460
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

IRS No.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33221 | Film No.: 231510224
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)